<DOC>
	<DOCNO>NCT01728636</DOCNO>
	<brief_summary>The purpose study determine tranexamic acid reduces perioperative blood loss red blood cell transfusion high risk spine surgery .</brief_summary>
	<brief_title>The Use Tranexamic Acid Reduce Perioperative Blood Loss During High Risk Spine Fusion Surgery</brief_title>
	<detailed_description>There conflict study literature report different efficacy outcome use antifibrinolytics spine fusion surgery . Several study support successful use tranexamic acid major orthopedic procedure , patient population study spine surgery thus far small highly variable , less clinically significant result . If TXA efficacious reduce perioperative blood loss , RBC transfusion without increase thromboembolic event , use may justify patient risk major blood transfusion .</detailed_description>
	<mesh_term>Spinal Curvatures</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>age &gt; 17 year undergoing posterior spine fusion surgery kyphoscoliosis &gt; 80 % chance major transfusion age &lt; 18 year nonEnglish speaking pregnancy emergency procedure surgery tumor , trauma infection severe coronary artery disease history venous thromboembolism history cerebral vascular accident history renal insufficiency allergy tranexamic acid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>